We are live on ! Find out more
VYGR icon

Voyager Therapeutics

43 hedge funds and large institutions have $86.5M invested in Voyager Therapeutics in 2016 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more funds holding

Funds holding: 3543 (+8)

8% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 13

62% less capital invested

Capital invested by funds: $225M → $86.5M (-$139M)

Holders
43
Holders Change
+8
Holders Change %
+22.86%
% of All Funds
1.15%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
14
Reduced
13
Closed
Calls
Puts
Net Calls
Net Calls Change

VYGR Hedge Fund Activity: Q1 2016 in Review

43 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q1 2016, worth a combined $86.5M — down 62% from $225M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new VYGR positions and 0 closed out — a net gain of 8 holders — while 14 added to existing stakes and 13 trimmed.

The largest buyer was Casdin Capital, adding an estimated $1.16M. The largest seller was Wellington Management Group, cutting an estimated $5.86M.

  • 43 institutional investors held Voyager Therapeutics (VYGR) as of Q1 2016, up from 35 in Q4 2015.
  • Funds reported $86.5M of Voyager Therapeutics stock for Q1 2016, down 62% quarter-over-quarter.
  • 8 funds opened new Voyager Therapeutics positions in Q1 2016 and 0 closed out, a net change of +8 holders.
  • The largest Voyager Therapeutics buyer in Q1 2016 was Casdin Capital, an estimated $1.16M added.
  • The largest Voyager Therapeutics seller in Q1 2016 was Wellington Management Group, an estimated $5.86M sold.

Based on aggregated 13F filings for Q1 2016.